Tyk2 is essential in NK cell function.

被引：0
|
作者：
Shimoda, K [1 ]
Kato, K [1 ]
Aoki, K [1 ]
Numata, A [1 ]
Takase, K [1 ]
Kamezaki, K [1 ]
Nagafuji, K [1 ]
Gondo, H [1 ]
Harada, M [1 ]
机构：
[1] Kyushu Univ, Grad Sch Med, Fukuoka 812, Japan
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3761
引用
收藏
页码：39B / 39B
页数：1
相关论文
共 50 条
  • [1] In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity
    Prchal-Murphy, Michaela
    Witalisz-Siepracka, Agnieszka
    Bednarik, Karoline T.
    Putz, Eva Maria
    Gotthardt, Dagmar
    Meissl, Katrin
    Sexl, Veronika
    Mueller, Mathias
    Strobl, Birgit
    ONCOIMMUNOLOGY, 2015, 4 (11):
  • [2] Non-canonical TYK2 governs NK cell-mediated tumour surveillance
    Witalisz-Siepracka, Agnieszka
    Prchal-Murphy, Michaela
    Bednarik, Karoline
    Meissl, Katrin
    Putz, Eva Maria
    Gotthardt, Dagmar
    Sexl, Veronika
    Strobl, Birgit
    Mueller, Mathias
    CYTOKINE, 2015, 76 (01) : 79 - 79
  • [3] Central TYK2 Inhibition Identifies TYK2 as a Key Neuroimmune Modulator
    Molitor, Tyler
    Hayashi, Genki
    Lin, Mei-Yao
    Dunn, Carissa
    Peterson, Nathan
    Poston, Robert
    Kurnellas, Michael
    Traver, David
    Patel, Seona
    Akgungor, Zeynep
    Leonardi, Virginia
    Lewis, Colizel
    Segales, Joshua
    Wood, Steve
    Rassoulpour, Arash
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 611 - 611
  • [4] Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 Inhibitors
    Du, Si-Shi
    Fang, Yu-Qing
    Zhang, Wen
    Rao, Guo-Wu
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (20) : 2900 - 2920
  • [5] Selective contribution of Tyk2 to cell activation by lipopolysaccharide
    Schneider, Andrea
    Reichart, Ursula
    Gerner, Wilhelm
    Kolbe, Thomas
    Saalmueller, Armin
    Mueller, Mathias
    FEBS LETTERS, 2008, 582 (25-26) : 3681 - 3686
  • [6] TYK2 in Tumor Immunosurveillance
    Karjalainen, Anzhelika
    Shoebridge, Stephen
    Krunic, Milica
    Simonovic, Natalija
    Tebb, Graham
    Macho-Maschler, Sabine
    Strobl, Birgit
    Mueller, Mathias
    CANCERS, 2020, 12 (01)
  • [7] Rapamycin inhibits NK cell function.
    Takeda, S
    Hsieh, C
    Ohara, H
    Martinez, OM
    Krams, SM
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 526 - 526
  • [8] Discovery of a Potent and Subtype-Selective Tyk2 Degrader Based on an Allosteric Tyk2 Inhibitor
    Kato, Jun-Ya
    Korenaga, Shigeru
    Iwakura, Masaru
    SSRN, 2022,
  • [9] Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2
    Liu, Chunjian
    Lin, James
    Langevine, Charles
    Smith, Daniel
    Li, Jianqing
    Tokarski, John S.
    Khan, Javed
    Ruzanov, Max
    Strnad, Joann
    Zupa-Fernandez, Adriana
    Cheng, Lihong
    Gillooly, Kathleen M.
    Shuster, David
    Zhang, Yifan
    Thankappan, Anil
    McIntyre, Kim W.
    Chaudhry, Charu
    Elzinga, Paul A.
    Chiney, Manoj
    Chimalakonda, Anjaneya
    Lombardo, Louis J.
    Macor, John E.
    Carter, Percy H.
    Burke, James R.
    Weinstein, David S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (01) : 677 - 694
  • [10] The role of Tyk2 in adaptive immunity
    Simma, O
    Sexl, V
    Stoiber, D
    PHARMACOLOGY, 2005, 75 (04) : 199 - 199
12345